Local delivery of a cancer-favoring oncolytic vaccinia virus via poly (lactic-co-glycolic acid) nanofiber for theranostic purposes
- Document Type
- Publications · Journal Article
- Registered DB
- SCIEScopus
- Journal Ranking
- JCR Q1Scopus Q1
- Journal
- INTERNATIONAL JOURNAL OF PHARMACEUTICS552(1-2) · pp.437 · 2018
- Citation
- Web of Science 34Scopus 39
- FWCI (Scopus)
- 1.7
- JCR IF
- JCR 2017 3.862
- ISSN
- 0378-5173
Authors
- Badrinath, NarayanasamyFirst authorBiomedical Science, School of Medicine, Pusan National University, Yangsan, South Korea
- Jeong, Young-IlResearch Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea
- Woo, Hyung-youngDepartment of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
- Bang, Seo YoungBIO-IT Foundry Technology Institute, Pusan National University, Busan, South Korea
- Kim, ChanAmogreentech Co. Ltd. Gyeonggi-do, South Korea
- Heo, JeongDepartment of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
- Kang, Dae-hwanDepartment of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
- Yoo, So YoungCorresponding authorResearch Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea
Abstract
Local delivery of viruses via nanomaterials has been demonstrated in the treatment of colon cancer. A cancer-favoring oncolytic vaccinia virus (CVV), which is an evolutionary cancer-favoring engineered vaccinia virus carrying the green fluorescent protein (GFP) gene, has antitumor efficacy in drug-resistant colon cancer and metastatic liver cells. Here, we present the antitumor efficacy of a CVV coated a poly lactic-co-glycolic acid (PLGA) nanofiber for local drug delivery in theranostic approaches. In vitro- and in vivo-based analyses using mouse colon carcinoma models confirmed the therapeutic efficacy of CVV-PLGA nanofibers through diagnostic localization of the tumors and reduced tumor burden as a result of enhanced apoptosis. We propose that the CVV-PLGA nanofiber may be used for theranostic purposes in cancer therapy.
Keywords
Poly (lactic-co-glycolic acid) nanofibersCancer-favoring oncolytic vaccinia virusCancer therapyTheranosticsHEPATOCELLULAR-CARCINOMAIN-VITROCONTROLLED-RELEASECOLORECTAL-CANCERLIVER-CANCERPOXVIRUSJX-594PLGATHERAPYNANOPARTICLES
Identifiers
- Scopus EID
- 2-s2.0-85054655559
- WoS UID
- 000447985800048



Login
Back to Publication list